Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
about
Restoration of PTEN expression alters the sensitivity of prostate cancer cells to EGFR inhibitors.EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancerTranscriptional Repressor DAXX Promotes Prostate Cancer Tumorigenicity via Suppression of Autophagy.Signaling mechanisms coupled to CXCL12/CXCR4-mediated cellular proliferation are PTEN-dependent.Mechanism of β-catenin-mediated transcriptional regulation of epidermal growth factor receptor expression in glycogen synthase kinase 3 β-inactivated prostate cancer cellsEpidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes.Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations.Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.In vitro differential sensitivity of melanomas to phenothiazines is based on the presence of codon 600 BRAF mutation.Therapeutic targeting of the mTOR-signalling pathway in cancer: benefits and limitationsTorc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models.Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines.Expression of TGFβ3 and its effects on migratory and invasive behavior of prostate cancer cells: involvement of PI3-kinase/AKT signaling pathway.EGFR- and AKT-mediated reduction in PTEN expression contributes to tyrphostin resistance and is reversed by mTOR inhibition in endometrial cancer cells.Antitumor effects of carnertinib in castration resistant prostate cancer models: a comparative study with erlotinib.Calcium-induced apoptosis is delayed by HER1 receptor signalling through the Akt and PLCγ pathways in bladder cancer cells.Pathogenesis of prostate cancer: lessons from basic research.Differential role of PTEN in transforming growth factor β (TGF-β) effects on proliferation and migration in prostate cancer cells.Combination of Carmustine and Selenite Inhibits EGFR Mediated Growth Signaling in Androgen-Independent Prostate Cancer Cells.The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258.hPEBP4 resists TRAIL-induced apoptosis of human prostate cancer cells by activating Akt and deactivating ERK1/2 pathways.
P2860
Q30438487-C05CA0FB-632F-4745-A991-E2F898A3F958Q35578652-8C3038E7-1246-4CF4-A2C7-070EF8B904D0Q35657164-91CA53AD-E01C-49B5-BBCB-8BDADC8D9D7AQ35860607-475F7E3E-45D2-43B7-8B72-16B0E78709BBQ35962850-EB103469-02CF-4F9A-B607-D388C2B7D6EFQ36002945-145F7EC1-FD0B-4627-AD74-862CF00C6C3AQ36010700-C30F6962-1E15-4119-B6DF-360468AB3825Q36742629-289E26E6-50FB-49A4-9145-336EF1E93414Q37230780-259BA936-F650-43B9-951C-E01C54F9BB01Q37250640-31A7F0BF-9F28-4ED8-98F1-D9C9CB794968Q38208069-821E9C5C-363C-47FD-8538-D89540150F9AQ39006052-3BB83830-C04D-41BC-B4EB-34582378B723Q39128526-A1CCB3BF-7BC5-4617-8F30-85FBAAC9C100Q39335055-FC1D3CF0-E302-49F0-A26F-D65061A30EAEQ39467200-3200EAEA-1FBB-4BF7-8132-5DE336484E99Q39568883-0C538DC4-6186-4D5E-A019-362FD7678A09Q39630184-8A65E588-AA56-49ED-BF14-0421F226829FQ42735276-78653365-79A9-4CA9-A560-13718634013CQ48229042-017302F3-9CEE-4849-880E-7A4EBEC93D28Q48248291-26BBEB07-2B91-4FEC-BA3A-7161CD46F37BQ53156735-D019FD74-0497-49CE-93F6-44246BE5B7E9Q53581949-3433F844-A55C-4D7D-AD0B-196D88256EC1
P2860
Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Molecular aspects of gefitinib ...... ve prostate cancer cell lines.
@en
type
label
Molecular aspects of gefitinib ...... ve prostate cancer cell lines.
@en
prefLabel
Molecular aspects of gefitinib ...... ve prostate cancer cell lines.
@en
P2093
P50
P356
P1476
Molecular aspects of gefitinib ...... ive prostate cancer cell lines
@en
P2093
P304
P356
10.1677/ERC.1.00986
P50
P577
2005-12-01T00:00:00Z